BWAY: BrainsWay Ltd. - Summary | Jitta

BrainsWay Ltd.

ISR:BWAY

Price
₪48.51
Loss Chance
44.6%
6.53JITTA SCORE
197.42%Over Jitta Line
Jitta Ranking
42 / 421
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (82)
Recent Business Performance (98)
Financial Strength (75)
Return to Shareholders (15)
Competitive Advantage (73)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2023
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
6.53
197.42%
2.84
95.01%
Health Care Equipment
2.49
100.00%
1.58
100.00%
0.77
100.00%
COMPANY DESCRIPTION
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.